Cervical cancer screening in Latvia: A brief history and recent improvements (2009-2011)

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 22, Issue 1, 2013, Pages 27-30

  Viberga, Ilze ^a   Poljak, Mario ^b  

^a UNIVERSITY OF LATVIA   (Latvia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CARCINOMA IN SITU; CYTOLOGY; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; LATVIA; PAPANICOLAOU TEST; UTERINE CERVIX CANCER;

ADULT; AGED; EARLY DETECTION OF CANCER; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LATVIA; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 84878063680     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10162-012-0027-y     Document Type: Article

References (7)

1. Anttila A, Ronco G. Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer. 2009;45:2685-708.
2. Anttila A, Arbyn M, Veerus P, Viberga I, Kurtinaitien R, Valerianova Z, et al. Barriers in cervical cancer screening programs in new European Union member states. Tumori. 2010;96:515-6.
3. Viberga I, Engele L, Baili P. Past, present and future of the cervical cancer screening in Latvia. Tumori. 2010;96:529-37.
4. Hakama M, Chamberlain J, Day NE, Miller AB, Prorok PC. Evaluation of screening programmes for gynaecological cancer. Br J Cancer. 1985;52:669-73.
5. Kesic V, Poljak M, Rogovskaya S. Cervical cancer burden and prevention activities in Europe. Cancer Epidemiol Biomarkers Prev. 2012;21:1423-33.
6. Poljak M, Cuzick J, Kocjan BJ, Iftner T, Dillner J, Arbyn M. Nucleic acid tests for the detection of alpha human papillomaviruses. Vaccine. 2012;Suppl 30:F100-6.
7. Arbyn M, Ronco G, Anttila A, Meijer CJLM, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;Suppl 30:F88-99.